Role of Chemokines in Rabies Pathogenesis and Protection

Advances in Virus Research

Volumn 79, Issue , 2011, Pages 73-89

  Niu, Xuefeng ^a   Wang, Hualei ^a   Fu, Zhen F ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Blood brain barrier; Central nervous system; Chemokines; Macrophage derived chemokine; Mouse hepatitis virus; Rabies virus; Virus neutralizing antibody

Indexed keywords

CHEMOKINE;

ANIMAL; BOOK; DISEASE MODEL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; MOUSE; PATHOGENICITY; PATHOLOGY; RABIES; RABIES VIRUS;

ANIMALS; CHEMOKINES; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; RABIES; RABIES VIRUS;

EID: 79956087834     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387040-7.00005-6     Document Type: Book

References (81)

1. Aravalli R.N., Hu S., Lokensgard J.R. Inhibition of toll-like receptor signaling in primary murine microglia. J. Neuroimmune Pharmacol. 2008, 3(1):5-11.
2. Barouch D.H., McKay P.F., Sumida S.M., Santra S., Jackson S.S., Gorgone D.A., Lifton M.A., Chakrabarti B.K., Xu L., Nabel G.J., Letvin N.L. Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines. J. Virol. 2003, 77(16):8729-8735.
3. Chantry D., Romagnani P., Raport C.J., Wood C.L., Epp A., Romagnani S., Gray P.W. Macrophage-derived chemokine is localized to thymic medullary epithelial cells and is a chemoattractant for CD3(+), CD4(+), CD8(low) thymocytes. Blood 1999, 94(6):1890-1898.
4. Chen I.Y., Chang S.C., Wu H.Y., Yu T.C., Wei W.C., Lin S., Chien C.L., Chang M.F. Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway. J. Virol. 2010, 84(15):7703-7712.
5. Christensen J.E., de Lemos C., Moos T., Christensen J.P., Thomsen A.R. CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system. J. Immunol. 2006, 176(7):4235-4243.
6. Christensen J.E., Simonsen S., Fenger C., Sorensen M.R., Moos T., Christensen J.P., Finsen B., Thomsen A.R. Fulminant lymphocytic choriomeningitis virus-induced inflammation of the CNS involves a cytokine-chemokine-cytokine-chemokine cascade. J. Immunol. 2009, 182(2):1079-1087.
7. Clark E.A. Regulation of B lymphocytes by dendritic cells. J. Exp. Med. 1997, 185(5):801-803.
8. Cyster J.G. Chemokines and cell migration in secondary lymphoid organs. Science 1999, 286(5447):2098-2102.
9. Dhingra V., Li X., Liu Y., Fu Z.F. Proteomic profiling reveals that rabies virus infection results in differential expression of host proteins involved in ion homeostasis and synaptic physiology in the central nervous system. J. Neurovirol. 2007, 13(2):107-117.
10. Dietzschold B., Morimoto K., Hooper D.C. Mechanisms of virus-induced neuronal damage and the clearance of viruses from the CNS. Curr. Top. Microbiol. Immunol. 2001, 253:145-155.
11. Dorries R. The role of T-cell-mediated mechanisms in virus infections of the nervous system. Curr. Top. Microbiol. Immunol. 2001, 253:219-245.
12. Dubois B., Bridon J.M., Fayette J., Barthelemy C., Banchereau J., Caux C., Briere F. Dendritic cells directly modulate B cell growth and differentiation. J. Leukoc. Biol. 1999, 66(2):224-230.
13. Fabis M.J., Phares T.W., Kean R.B., Koprowski H., Hooper D.C. Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity. Proc. Natl. Acad. Sci. USA 2008, 105(40):15511-15516.
14. Fisher S.N., Vanguri P., Shin H.S., Shin M.L. Regulatory mechanisms of MuRantes and CRG-2 chemokine gene induction in central nervous system glial cells by virus. Brain Behav. Immun. 1995, 9(4):331-344.
15. Fu Z.F. Rabies and rabies research: Past, present and future. Vaccine 1997, 15(Suppl.):S20-S24.
16. Fu Z.F., Weihe E., Zheng Y.M., Schafer M.K., Sheng H., Corisdeo S., Rauscher F.J., Koprowski H., Dietzschold B. Differential effects of rabies and borna disease viruses on immediate-early- and late-response gene expression in brain tissues. J. Virol. 1993, 67(11):6674-6681.
17. Fung-Leung W.P., Kundig T.M., Zinkernagel R.M., Mak T.W. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression. J. Exp. Med. 1991, 174(6):1425-1429.
18. Gale L.M., McColl S.R. Chemokines: Extracellular messengers for all occasions?. Bioessays 1999, 21(1):17-28.
19. Gibson S.J., Lindh J.M., Riter T.R., Gleason R.M., Rogers L.M., Fuller A.E., Oesterich J.L., Gorden K.B., Qiu X., McKane S.W., Noelle R.J., Miller R.L., et al. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. Cell. Immunol. 2002, 218(1-2):74-86.
20. Glabinski A.R., Ransohoff R.M. Sentries at the gate: Chemokines and the blood-brain barrier. J. Neurovirol. 1999, 5(6):623-634.
21. Glass W.G., Hickey M.J., Hardison J.L., Liu M.T., Manning J.E., Lane T.E. Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J. Immunol. 2004, 172(7):4018-4025.
22. Glass W.G., Lim J.K., Cholera R., Pletnev A.G., Gao J.L., Murphy P.M. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 2005, 202(8):1087-1098.
23. Glass W.G., McDermott D.H., Lim J.K., Lekhong S., Yu S.F., Frank W.A., Pape J., Cheshier R.C., Murphy P.M. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J. Exp. Med. 2006, 203(1):35-40.
24. Godiska R., Chantry D., Raport C.J., Sozzani S., Allavena P., Leviten D., Mantovani A., Gray P.W. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J. Exp. Med. 1997, 185(9):1595-1604.
25. Hamilton J.A., Anderson G.P. GM-CSF biology. Growth Factors 2004, 22(4):225-231.
26. Han Y.W., Aleyas A.G., George J.A., Kim S.J., Kim H.K., Yoo D.J., Kang S.H., Eo S.K. Genetic co-transfer of CCR7 ligands enhances immunity and prolongs survival against virulent challenge of pseudorabies virus. Immunol. Cell Biol. 2009, 87(1):91-99.
27. Hofer M.J., Carter S.L., Muller M., Campbell I.L. Unaltered neurological disease and mortality in CXCR3-deficient mice infected intracranially with lymphocytic choriomeningitis virus-Armstrong. Viral Immunol. 2008, 21(4):425-433.
28. Holman D.W., Klein R.S., Ransohoff R.M. The blood-brain barrier, chemokines and multiple sclerosis. Biochim. Biophys. Acta. 2010, 1812(2):220-230.
29. Hooper D.C., Morimoto K., Bette M., Weihe E., Koprowski H., Dietzschold B. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J. Virol. 1998, 72(5):3711-3719.
30. Hooper D.C., Phares T.W., Fabis M.J., Roy A. The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system. PLoS Negl. Trop. Dis. 2009, 3(10):e535.
31. Hosking M.P., Lane T.E. The role of chemokines during viral infection of the CNS. PLoS Pathog. 2010, 6(7):e1000937.
32. Iellem A., Mariani M., Lang R., Recalde H., Panina-Bordignon P., Sinigaglia F., D'Ambrosio D. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 2001, 194(6):847-853.
33. Imai T., Nagira M., Takagi S., Kakizaki M., Nishimura M., Wang J., Gray P.W., Matsushima K., Yoshie O. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int. Immunol. 1999, 11(1):81-88.
34. Kim T.S., Perlman S. Viral expression of CCL2 is sufficient to induce demyelination in RAG1-/- mice infected with a neurotropic coronavirus. J. Virol. 2005, 79(11):7113-7120.
35. Kim J.V., Kang S.S., Dustin M.L., McGavern D.B. Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 2009, 457(7226):191-195.
36. Kuang Y., Lackay S.N., Zhao L., Fu Z.F. Role of chemokines in the enhancement of BBB permeability and inflammatory infiltration after rabies virus infection. Virus Res. 2009, 144(1-2):18-26.
37. Kutzler M.A., Kraynyak K.A., Nagle S.J., Parkinson R.M., Zharikova D., Chattergoon M., Maguire H., Muthumani K., Ugen K., Weiner D.B. Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo. Gene Ther. 2010, 17(1):72-82.
38. Lackay S.N., Kuang Y., Fu Z.F. Rabies in small animals. Vet. Clin. North Am. Small Anim. Pract. 2008, 38(4):851-861. ix.
39. Lima G.K., Zolini G.P., Mansur D.S., Freire Lima B.H., Wischhoff U., Astigarraga R.G., Dias M.F., Silva M.D., Bela S.R., do Valle Antonelli L.R., Arantes R.M., Gazzinelli R.T., et al. Toll-like receptor (TLR) 2 and TLR9 expressed in trigeminal ganglia are critical to viral control during herpes simplex virus 1 infection. Am. J. Pathol. 2010, 177(5):2433-2445.
40. Lin A.A., Tripathi P.K., Sholl A., Jordan M.B., Hildeman D.A. Gamma interferon signaling in macrophage lineage cells regulates central nervous system inflammation and chemokine production. J. Virol. 2009, 83(17):8604-8615.
41. Liu M.T., Keirstead H.S., Lane T.E. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J. Immunol. 2001, 167(7):4091-4097.
42. Mansfield K.L., Johnson N., Nunez A., Hicks D., Jackson A.C., Fooks A.R. Up-regulation of chemokine gene transcripts and T-cell infiltration into the central nervous system and dorsal root ganglia are characteristics of experimental European bat lyssavirus type 2 infection of mice. J. Neurovirol. 2008, 14(3):218-228.
43. Martinez L. Global infectious disease surveillance. Int. J. Infect. Dis. 2000, 4(4):222-228.
44. Masatani T., Ito N., Shimizu K., Ito Y., Nakagawa K., Sawaki Y., Koyama H., Sugiyama M. Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response. J. Virol. 2010, 84(8):4002-4012.
45. Maurer M., von Stebut E. Macrophage inflammatory protein-1. Int. J. Biochem. Cell Biol. 2004, 36(10):1882-1886.
46. McKay P.F., Barouch D.H., Santra S., Sumida S.M., Jackson S.S., Gorgone D.A., Lifton M.A., Letvin N.L. Recruitment of different subsets of antigen-presenting cells selectively modulates DNA vaccine-elicited CD4(+) and CD8(+) T lymphocyte responses. Eur. J. Immunol. 2004, 34(4):1011-1020.
47. Meslin F.X., Fishbein D.B., Matter H.C. Rationale and prospects for rabies elimination in developing countries. Curr. Top. Microbiol. Immunol. 1994, 187:1-26.
48. Metcalf D. Hematopoietic cytokines. Blood 2008, 111(2):485-491.
49. Miyamoto K., Matsumoto S. Comparative studies between pathogenesis of street and fixed rabies infection. J. Exp. Med. 1967, 125(3):447-456.
50. Morimoto K., Patel M., Corisdeo S., Hooper D.C., Fu Z.F., Rupprecht C.E., Koprowski H., Dietzschold B. Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proc. Natl. Acad. Sci. USA 1996, 93(11):5653-5658.
51. Moser B., Loetscher P. Lymphocyte traffic control by chemokines. Nat. Immunol. 2001, 2(2):123-128.
52. Murphy F.A. Rabies pathogenesis. Arch. Virol. 1977, 54(4):279-297.
53. Nakamichi K., Inoue S., Takasaki T., Morimoto K., Kurane I. Rabies virus stimulates nitric oxide production and CXC chemokine ligand 10 expression in macrophages through activation of extracellular signal-regulated kinases 1 and 2. J. Virol. 2004, 78(17):9376-9388.
54. Nakamichi K., Saiki M., Sawada M., Takayama-Ito M., Yamamuro Y., Morimoto K., Kurane I. Rabies virus-induced activation of mitogen-activated protein kinase and NF-kappaB signaling pathways regulates expression of CXC and CC chemokine ligands in microglia. J. Virol. 2005, 79(18):11801-11812.
55. Pachter J.S., de Vries H.E., Fabry Z. The blood-brain barrier and its role in immune privilege in the central nervous system. J. Neuropathol. Exp. Neurol. 2003, 62(6):593-604.
56. Patterson C.E., Daley J.K., Echols L.A., Lane T.E., Rall G.F. Measles virus infection induces chemokine synthesis by neurons. J. Immunol. 2003, 171(6):3102-3109.
57. Phares T.W., Kean R.B., Mikheeva T., Hooper D.C. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J. Immunol. 2006, 176(12):7666-7675.
58. Pinto A.R., Reyes-Sandoval A., Ertl H.C. Chemokines and TRANCE as genetic adjuvants for a DNA vaccine to rabies virus. Cell. Immunol. 2003, 224(2):106-113.
59. Prehaud C., Megret F., Lafage M., Lafon M. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J. Virol. 2005, 79(20):12893-12904.
60. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 2000, 18:217-242.
61. Roy A., Hooper D.C. Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J. Virol. 2007, 81(15):7993-7998.
62. Roy A., Phares T.W., Koprowski H., Hooper D.C. Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection. J. Virol. 2007, 81(3):1110-1118.
63. Sallusto F., Palermo B., Lenig D., Miettinen M., Matikainen S., Julkunen I., Forster R., Burgstahler R., Lipp M., Lanzavecchia A. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 1999, 29(5):1617-1625.
64. Sarmento L., Li X.Q., Howerth E., Jackson A.C., Fu Z.F. Glycoprotein-mediated induction of apoptosis limits the spread of attenuated rabies viruses in the central nervous system of mice. J. Neurovirol. 2005, 11(6):571-581.
65. Schaniel C., Pardali E., Sallusto F., Speletas M., Ruedl C., Shimizu T., Seidl T., Andersson J., Melchers F., Rolink A.G., Sideras P. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. J. Exp. Med. 1998, 188(3):451-463.
66. So E.Y., Kim B.S. Theiler's virus infection induces TLR3-dependent upregulation of TLR2 critical for proinflammatory cytokine production. Glia 2009, 57(11):1216-1226.
67. Stiles L.N., Liu M.T., Kane J.A., Lane T.E. CXCL10 and trafficking of virus-specific T cells during coronavirus-induced demyelination. Autoimmunity 2009, 42(6):484-491.
68. Thapa M., Carr D.J. Herpes simplex virus type 2-induced mortality following genital infection is blocked by anti-tumor necrosis factor alpha antibody in CXCL10-deficient mice. J. Virol. 2008, 82(20):10295-10301.
69. Thapa M., Kuziel W.A., Carr D.J. Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J. Virol. 2007, 81(8):3704-3713.
70. Ubogu E.E., Cossoy M.B., Ransohoff R.M. The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol. Sci. 2006, 27(1):48-55.
71. Vanguri P., Farber J.M. IFN and virus-inducible expression of an immediate early gene, crg-2/IP-10, and a delayed gene, I-A alpha in astrocytes and microglia. J. Immunol. 1994, 152(3):1411-1418.
72. Wang Z.W., Sarmento L., Wang Y., Li X.Q., Dhingra V., Tseggai T., Jiang B., Fu Z.F. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J. Virol. 2005, 79(19):12554-12565.
73. Wang, H. and Fu, Z. F. (unpublished data).
74. Wen Y., Wang H., Wu H., Tripp R.A., Hogan R.J., Fu Z.F. Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination. J. Virol 2011, 85:1634-1644.
75. Wu M., Fang H., Hwang S.T. Cutting edge: CCR4 mediates antigen-primed T cell binding to activated dendritic cells. J. Immunol. 2001, 167(9):4791-4795.
76. Yan X., Prosniak M., Curtis M.T., Weiss M.L., Faber M., Dietzschold B., Fu Z.F. Silver-haired bat rabies virus variant does not induce apoptosis in the brain of experimentally infected mice. J. Neurovirol. 2001, 7(6):518-527.
77. Yoshie O., Imai T., Nomiyama H. Chemokines in immunity. Adv. Immunol. 2001, 78:57-110.
78. Zhang B., Chan Y.K., Lu B., Diamond M.S., Klein R.S. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J. Immunol. 2008, 180(4):2641-2649.
79. Zhao L., Toriumi H., Kuang Y., Chen H., Fu Z.F. The roles of chemokines in rabies virus infection: Overexpression may not always be beneficial. J. Virol. 2009, 83(22):11808-11818.
80. Zhao L., Toriumi H., Wang H., Kuang Y., Guo X., Morimoto K., Fu Z.F. Expression of MIP-1alpha (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells. J. Virol. 2010, 84(18):9642-9648.
81. Zlotnik A., Yoshie O. Chemokines: A new classification system and their role in immunity. Immunity 2000, 12(2):121-127.